Back to Journals » Reports in Medical Imaging » Volume 3

Cardiac MRI detection of a rare case of familial cardiac amyloidosis (Ser23Asn): case report with literature review

Authors Joseph Daoko, Elnahar Y, El Kersh K, Mohammad N, Shamoon F

Published 8 December 2010 Volume 2010:3 Pages 123—127

DOI https://doi.org/10.2147/RMI.S14552

Review by Single-blind

Peer reviewer comments 4


Joseph Daoko, Yaser Elnahar, Karim El Kersh, Naser Mohammad, Fayez Shamoon
St Michael's Medical Center, Newark, NJ, USA

Abstract: Cardiac amyloidosis is a rare disease that has significant sequelae if undetected and treated early. We report a case of a rare genetic mutation that leads to cardiac amyloidosis. This is a case of a 41-year-old Peruvian male without any known past medical history but with a family history of sudden death. The patient complained of episodic left-sided chest pain for 1 month that was associated with shortness of breath. A subsequent admission and workup for coronary artery disease was negative, but an echocardiogram showed global left ventricular hypokinesia. Cardiac magnetic resonance imaging (MRI) was performed which was suggestive of cardiac amyloidosis. A subsequent abdominal fat biopsy and bone marrow biopsy failed to show evidence of amyloidosis. However, the endomyocardial biopsy was consistent with cardiac amyloidosis. Familial cardiac disease was suspected because of the family history of sudden death. As such, genetic testing was performed which yielded a very rare genetic mutation corresponding to amino acid 23 of the transthyretin protein. A review of the literature shows that this gene mutation (AGT23AAT, gene sequence; Ser23Asn, protein sequence) has been described only once previously. This case is unique in that the patient's amyloidosis was limited to the heart, without involvement of any other organ.

Keywords: amyloidosis, mutation, cardiac disease, genetics, diagnosis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]